US7071304B2
(en)
*
|
1998-09-01 |
2006-07-04 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
DE19951360A1
(de)
*
|
1999-10-26 |
2001-05-03 |
Aventis Pharma Gmbh |
Substituierte Indole
|
JP2001131151A
(ja)
*
|
1999-11-02 |
2001-05-15 |
Shionogi & Co Ltd |
オレフィン誘導体の新規用途
|
JP4285602B2
(ja)
|
2000-10-26 |
2009-06-24 |
アムジェン インコーポレイテッド |
抗炎症剤
|
DE10115073A1
(de)
*
|
2001-03-27 |
2002-10-10 |
Procorde Gmbh |
Verwendung von Inhibitoren von IKK-ß und Verfahren zum Auffinden solcher Inhibitoren
|
SK12002003A3
(en)
*
|
2001-03-28 |
2004-10-05 |
Bristol Myers Squibb Co |
Novel tyrosine kinase inhibitors
|
US7405235B2
(en)
*
|
2001-05-04 |
2008-07-29 |
Paratek Pharmaceuticals, Inc. |
Transcription factor modulating compounds and methods of use thereof
|
JP4933730B2
(ja)
*
|
2001-05-04 |
2012-05-16 |
パラテック ファーマシューティカルズ インコーポレイテッド |
転写因子調節化合物およびその使用法
|
AU2002316765B2
(en)
*
|
2001-06-13 |
2007-04-05 |
Bhp Billiton Sa Limited |
Solvent extraction mixture comprising substituted imidazole or benzimidazole for the separation of groups of base metals
|
CA2450443C
(fr)
*
|
2001-06-13 |
2009-12-15 |
Bhp Billiton Sa Limited |
Melange d'extraction par solvant pour effectuer l'epuration de metaux communs
|
US8124625B2
(en)
|
2001-09-14 |
2012-02-28 |
Shionogi & Co., Ltd. |
Method of enhancing the expression of apolipoprotein AI using olefin derivatives
|
IL161576A0
(en)
*
|
2001-10-26 |
2004-09-27 |
Aventis Pharma Inc |
Benzimidazoles and analogues and their use as protein kinases inhibitors
|
FR2831536A1
(fr)
*
|
2001-10-26 |
2003-05-02 |
Aventis Pharma Sa |
Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
|
FR2831537B1
(fr)
*
|
2001-10-26 |
2008-02-29 |
Aventis Pharma Sa |
Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation
|
US6897208B2
(en)
|
2001-10-26 |
2005-05-24 |
Aventis Pharmaceuticals Inc. |
Benzimidazoles
|
WO2003048152A2
(fr)
|
2001-12-05 |
2003-06-12 |
Tularik Inc. |
Modulateurs d'inflammation
|
PT1474425E
(pt)
|
2002-01-07 |
2006-09-29 |
Eisai Co Ltd |
Desazapurinas e sua utilizacao
|
EP1469875A1
(fr)
|
2002-01-29 |
2004-10-27 |
Wyeth |
Compositions et procedes de modulation des demi-canaux de connexines
|
US7199990B2
(en)
|
2002-01-30 |
2007-04-03 |
Siemens Aktiengesellschaft |
Device for short-circuiting two electric lines for reducing a voltage differential
|
EP2322521B1
(fr)
*
|
2002-02-06 |
2013-09-04 |
Vertex Pharmaceuticals, Inc. |
Composés hétéroaryle utiles comme inhibiteurs de GSK-3
|
US7528161B2
(en)
*
|
2002-05-31 |
2009-05-05 |
Michigan State University |
NF-kappaB inhibitors and uses thereof
|
US20080114015A1
(en)
*
|
2002-05-31 |
2008-05-15 |
Board Of Trustees Of Michigan State University |
NF-kB inhibitors and uses thereof
|
US6974870B2
(en)
|
2002-06-06 |
2005-12-13 |
Boehringer Ingelheim Phamaceuticals, Inc. |
Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
|
WO2003103661A1
(fr)
|
2002-06-06 |
2003-12-18 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
COMPOSES AMIDE D'ACIDE 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIQUE SUBSTITUES ET PROCESSUS DE PREPARATION ET D'UTILISATION DE CES COMPOSES
|
ES2378987T3
(es)
*
|
2002-08-06 |
2012-04-19 |
Toray Industries, Inc. |
Remedio o agente preventivo para una enfermedad renal y procedimiento para diagnosticar una enfermedad renal
|
PL374971A1
(en)
*
|
2002-08-09 |
2005-11-14 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds and methods to modulate coagulation
|
DE10237723A1
(de)
*
|
2002-08-17 |
2004-07-08 |
Aventis Pharma Deutschland Gmbh |
Verwendung von IKappaB-Kinase Inhibitoren in der Schmerztherapie
|
US7462638B2
(en)
*
|
2002-08-17 |
2008-12-09 |
Sanofi-Aventis Deutschland Gmbh |
Use of IκB-kinase inhibitors in pain therapy
|
DE10237722A1
(de)
|
2002-08-17 |
2004-08-19 |
Aventis Pharma Deutschland Gmbh |
Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
|
DE10238002A1
(de)
*
|
2002-08-20 |
2004-03-04 |
Merck Patent Gmbh |
Benzimidazolderivate
|
RS20050195A
(en)
*
|
2002-09-17 |
2007-08-03 |
Warner Lambert Company Llc., |
Heterocyclic substituted piperazines for the treatment of schizophrenia
|
WO2004041285A1
(fr)
|
2002-10-31 |
2004-05-21 |
Amgen Inc. |
Agents anti-inflammatoires
|
AU2003286757B2
(en)
*
|
2002-11-01 |
2009-06-04 |
Merck Sharp & Dohme Corp. |
Carbonylamino-benzimidazole derivatives as androgen receptor modulators
|
US7640843B2
(en)
*
|
2003-01-24 |
2010-01-05 |
Kraft Foods R & D, Inc. |
Cartridge and method for the preparation of beverages
|
US20050256132A1
(en)
*
|
2003-04-30 |
2005-11-17 |
Wyeth |
Use of ER selective NF-kB inhibitors for the treatment of sepsis
|
US20050004164A1
(en)
*
|
2003-04-30 |
2005-01-06 |
Caggiano Thomas J. |
2-Cyanopropanoic acid amide and ester derivatives and methods of their use
|
JP2007515937A
(ja)
*
|
2003-05-08 |
2007-06-21 |
ベス イスラエル デアコネス メディカル センター インコーポレイティッド |
NF−κBの調節機構
|
TWI372050B
(en)
*
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
US7501538B2
(en)
*
|
2003-08-08 |
2009-03-10 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds, compositions and methods of use
|
US7208601B2
(en)
*
|
2003-08-08 |
2007-04-24 |
Mjalli Adnan M M |
Aryl and heteroaryl compounds, compositions, and methods of use
|
CA2531796A1
(fr)
*
|
2003-08-08 |
2005-02-17 |
Transtech Pharma, Inc. |
Composes aryle et heteroaryle, compositions et procedes d'utilisation
|
PT1682553E
(pt)
*
|
2003-09-08 |
2010-07-29 |
Aventis Pharma Inc |
Tienopirazoles
|
WO2005040355A2
(fr)
*
|
2003-10-24 |
2005-05-06 |
Exelixis, Inc. |
Modulateurs de kinases tao et leurs methodes d'utilisation
|
US7119102B2
(en)
*
|
2003-12-05 |
2006-10-10 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
|
US20060160799A1
(en)
|
2004-04-23 |
2006-07-20 |
Alekshun Michael N |
Transcription factor modulating compounds and methods of use thereof
|
US7425580B2
(en)
|
2004-05-19 |
2008-09-16 |
Wyeth |
(Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands
|
AR050253A1
(es)
|
2004-06-24 |
2006-10-11 |
Smithkline Beecham Corp |
Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento
|
NZ555982A
(en)
*
|
2004-12-30 |
2011-01-28 |
Astex Therapeutics Ltd |
Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases
|
JP2008526721A
(ja)
*
|
2004-12-30 |
2008-07-24 |
アステックス、セラピューティックス、リミテッド |
Cdk、gsk及びオーロラキナーゼの活性を調節するチアゾールおよびイソチアゾール誘導体
|
WO2006099379A2
(fr)
*
|
2005-03-14 |
2006-09-21 |
Transtech Pharma, Inc. |
Derives de benzazole, compositions et methodes d'utilisation des derives comme inhibiteurs de la b-secretase
|
BRPI0608944A2
(pt)
*
|
2005-03-30 |
2010-11-16 |
Takeda Pharmaceutical |
composto, cristal, método para produzir um composto, agente farmacêutico, sensor de insulina, melhorador de uma atividade hipoglicêmica de um sensor de insulina, e, uso composto
|
TWI370820B
(en)
*
|
2005-04-27 |
2012-08-21 |
Takeda Pharmaceutical |
Fused heterocyclic compounds
|
CA2613068A1
(fr)
|
2005-06-30 |
2007-01-11 |
Smithkline Beecham Corporation |
Indole carboxamides en tant qu'inhibiteurs d'ikk2
|
US8063071B2
(en)
|
2007-10-31 |
2011-11-22 |
GlaxoSmithKline, LLC |
Chemical compounds
|
ES2431050T3
(es)
|
2005-08-04 |
2013-11-22 |
Sirtris Pharmaceuticals, Inc. |
Benzotiazoles y tiazolopiridinas como moduladores de la sirtuína
|
US8088928B2
(en)
|
2005-08-04 |
2012-01-03 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
US8093401B2
(en)
|
2005-08-04 |
2012-01-10 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
US7855289B2
(en)
|
2005-08-04 |
2010-12-21 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
JP2009001495A
(ja)
*
|
2005-10-13 |
2009-01-08 |
Taisho Pharmaceutical Co Ltd |
2−アリール−ベンゾイミダゾール−5−カルボキサミド誘導体
|
EP1968579A1
(fr)
*
|
2005-12-30 |
2008-09-17 |
Astex Therapeutics Limited |
Composes pharmaceutiques
|
US20070232673A1
(en)
*
|
2006-01-19 |
2007-10-04 |
Roth Gregory P |
2-Imino-benzimidazoles
|
NZ571691A
(en)
|
2006-03-31 |
2011-07-29 |
Janssen Pharmaceutica Nv |
Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor
|
AU2007235577B2
(en)
*
|
2006-03-31 |
2011-09-15 |
Janssen Pharmaceutica N.V. |
Benzoimidazol-2-yl pyridines as modulators of the histamine H4 receptor
|
WO2007146602A1
(fr)
|
2006-06-06 |
2007-12-21 |
Boehringer Ingelheim International Gmbh |
COMPOSÉS AMIDE DE L'ACIDE 3-AMINO-THIÉNO[2,3-b]PYRIDINE-2-CARBOXYLIQUE SUBSTITUÉS, PROCÉDÉS DE PRÉPARATION ET LEURS UTILISATIONS
|
US20090170812A1
(en)
*
|
2006-06-23 |
2009-07-02 |
Paratek Pharmaceuticals, Inc. |
Transcription factor modulating compounds and methods of use thereof
|
US20110159111A1
(en)
*
|
2006-06-29 |
2011-06-30 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
JP5523829B2
(ja)
*
|
2006-06-29 |
2014-06-18 |
アステックス、セラピューティックス、リミテッド |
複合薬剤
|
WO2008017381A1
(fr)
|
2006-08-08 |
2008-02-14 |
Sanofi-Aventis |
Imidazolidin-2,4-dione arylaminoaryl-alkyl-substituée, son procédé de fabrication, médicament contenant ce composé et son utilisation
|
NZ575410A
(en)
*
|
2006-09-07 |
2012-03-30 |
Biogen Idec Inc |
2-(1H-Indazol-3-ylamino)-1H-benzimidazole derivatives
|
PE20080888A1
(es)
*
|
2006-10-18 |
2008-08-26 |
Novartis Ag |
COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE LA ACIL-TRANSFERASA DE ACIL-CoA-DIACIL-GLICEROL 1 (DGAT1)
|
PE20081889A1
(es)
|
2007-03-23 |
2009-03-05 |
Smithkline Beecham Corp |
Indol carboxamidas como inhibidores de ikk2
|
EP2139474A2
(fr)
*
|
2007-03-27 |
2010-01-06 |
Paratek Pharmaceuticals, Inc. |
Composés modulant le facteur de transcription et leurs procédés d'utilisation
|
CL2008001822A1
(es)
|
2007-06-20 |
2009-03-13 |
Sirtris Pharmaceuticals Inc |
Compuestos derivados de tiazolo[5,4-b]piridina; composicion farmaceutica que comprende a dichos compuestos; y uso del compuesto en el tratamiento de la resistencia a la insulina, sindrome metabolico, diabetes, entre otras.
|
EP2025674A1
(fr)
|
2007-08-15 |
2009-02-18 |
sanofi-aventis |
Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament
|
WO2009049238A1
(fr)
|
2007-10-11 |
2009-04-16 |
The Regents Of The University Of California |
Compositions et procédés d'inhibition de l'amidase acide d'hydrolyse de la n-acyléthanolamine
|
WO2009079001A1
(fr)
|
2007-12-18 |
2009-06-25 |
Janssen Pharmaceutica N.V. |
Imidazoles bicycliques substitué par hétéroaryle constituant des modulateurs du récepteur de l'histamine h4
|
CN104491864A
(zh)
|
2008-04-21 |
2015-04-08 |
奥德纳米有限公司 |
用于治疗耳部疾病和病况的耳用调配物及方法
|
US11969501B2
(en)
|
2008-04-21 |
2024-04-30 |
Dompé Farmaceutici S.P.A. |
Auris formulations for treating otic diseases and conditions
|
WO2009134847A1
(fr)
*
|
2008-04-30 |
2009-11-05 |
Smithkline Beecham Corporation |
Inhibiteurs de la prolylhydroxylase
|
US9371311B2
(en)
|
2008-06-30 |
2016-06-21 |
Janssen Pharmaceutica Nv |
Benzoimidazol-2-yl pyrimidine derivatives
|
CN104193740A
(zh)
*
|
2008-07-03 |
2014-12-10 |
西特里斯药业公司 |
作为沉默调节蛋白调节剂的苯并咪唑类和相关的类似物
|
TW201014822A
(en)
|
2008-07-09 |
2010-04-16 |
Sanofi Aventis |
Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
|
WO2010068601A1
(fr)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
Hydrate de fluoroglycoside hétéroaromatique cristallin, ses procédés de fabrication, ses procédés d'utilisation et compositions pharmaceutiques le contenant
|
UA104447C2
(uk)
|
2008-12-19 |
2014-02-10 |
Сіртріз Фармасьютікалз, Інк. |
Тіазолопіридинові сполуки, що модулюють сиртуїн
|
WO2010102968A1
(fr)
|
2009-03-10 |
2010-09-16 |
Glaxo Group Limited |
Dérivés d'indole comme inhibiteurs de ikk2
|
WO2010124097A2
(fr)
*
|
2009-04-22 |
2010-10-28 |
Paratek Pharmaceuticals, Inc. |
Composés modulateurs de facteur de transcription et leurs procédés d'utilisation
|
EP2464231A4
(fr)
*
|
2009-08-10 |
2013-02-06 |
Samumed Llc |
Indazoles utiles comme inhibiteurs de la voie de signalisation de wnt/bêta-caténine et utilisations thérapeutiques de ceux-ci
|
CA2770116C
(fr)
|
2009-08-10 |
2018-03-13 |
Epitherix, Llc |
Composes d?indazole inhibant la voie de signalisation des wnt et utilisations therapeutiques de ceux-ci thereof
|
SG178880A1
(en)
|
2009-08-26 |
2012-04-27 |
Sanofi Sa |
Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
|
US20120263646A1
(en)
*
|
2009-10-15 |
2012-10-18 |
Guerbet |
Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
|
PT3001903T
(pt)
*
|
2009-12-21 |
2017-12-18 |
Samumed Llc |
1h-pirazolo[3,4-b]piridinas e usos terapêuticos destas
|
NZ602395A
(en)
*
|
2010-02-18 |
2014-05-30 |
High Point Pharmaceuticals Llc |
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
|
US8759535B2
(en)
|
2010-02-18 |
2014-06-24 |
High Point Pharmaceuticals, Llc |
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
|
WO2011107494A1
(fr)
|
2010-03-03 |
2011-09-09 |
Sanofi |
Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation
|
US8933024B2
(en)
|
2010-06-18 |
2015-01-13 |
Sanofi |
Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
TW201215387A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Aventis |
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
WO2012120054A1
(fr)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation
|
EP2683699B1
(fr)
|
2011-03-08 |
2015-06-24 |
Sanofi |
Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation
|
WO2012120052A1
(fr)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Dérivés d'oxathiazine substitués par des carbocycles ou des hétérocycles, leur procédé de préparation, médicaments contenant ces composés et leur utilisation
|
US8809325B2
(en)
|
2011-03-08 |
2014-08-19 |
Sanofi |
Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
|
EP2683702B1
(fr)
|
2011-03-08 |
2014-12-24 |
Sanofi |
Nouveaux dérivés de phényle-oxathiazine substitués, leur procédé de fabrication, médicament contenant ces liaisons et son utilisation
|
WO2012120056A1
(fr)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Dérivés oxathiazine tétra-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation
|
US8895547B2
(en)
|
2011-03-08 |
2014-11-25 |
Sanofi |
Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
|
US8828995B2
(en)
|
2011-03-08 |
2014-09-09 |
Sanofi |
Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
US8846666B2
(en)
|
2011-03-08 |
2014-09-30 |
Sanofi |
Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
|
EP2704700B1
(fr)
|
2011-04-29 |
2018-06-27 |
Emory University |
Utilisation sélective d'inhibiteurs du protéasome sur la base de la séquence de nf-kb2
|
WO2013037390A1
(fr)
|
2011-09-12 |
2013-03-21 |
Sanofi |
Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
|
IN2014CN02646A
(fr)
|
2011-09-14 |
2015-08-07 |
Samumed Llc |
|
WO2013045413A1
(fr)
|
2011-09-27 |
2013-04-04 |
Sanofi |
Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b] pyridine-4-carboxylique utilisés comme inhibiteurs de kinase
|
US9353075B2
(en)
|
2011-11-22 |
2016-05-31 |
The Regents Of The University Of California |
Disubstituted beta-lactones as inhibitors of N-acylethanolamine acid amidase (NAAA)
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
PT2770994T
(pt)
|
2012-05-04 |
2019-11-04 |
Samumed Llc |
1h-pirazolo[3,4-b]piridinas e utilizações terapêuticas destas
|
EP2943198B1
(fr)
|
2013-01-08 |
2019-07-17 |
Samumed, LLC |
Inhibiteurs de 3-(benzoimidazol-2-yl)-indazole de la voie de signalisation par wnt et leurs utilisations thérapeutiques
|
UY35370A
(es)
|
2013-03-06 |
2014-09-30 |
Janssen Pharmaceutica Nv |
Moduladores benzoimidazol-2-il pirimidina del receptor de histamina h4
|
WO2014144547A2
(fr)
|
2013-03-15 |
2014-09-18 |
The Regents Of The University Of California |
Dérivés d'amide d'inhibiteurs de l'amidase acide de n-acyléthanolamine à base de lactame
|
WO2014144836A2
(fr)
|
2013-03-15 |
2014-09-18 |
The Regents Of The University Of California |
Dérivés de carbamate d'inhibiteurs d'amidase acide de n-acyléthanolamine (naaa) à base de lactame
|
EP3087054A4
(fr)
|
2013-12-27 |
2017-10-25 |
Novus International Inc. |
Tensioactifs ethoxylés
|
PL3102576T3
(pl)
|
2014-02-03 |
2019-12-31 |
Vitae Pharmaceuticals, Llc |
Dihydropirolopirydynowe inhibitory ror-gamma
|
WO2016040182A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine et ses utilisations thérapeutiques
|
WO2016040193A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine et ses utilisations thérapeutiques
|
WO2016040188A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
WO2016040184A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
WO2016040180A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
WO2016040185A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine et ses utilisations thérapeutiques
|
WO2016040190A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine et ses utilisations thérapeutiques
|
WO2016040181A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
WO2016089648A1
(fr)
|
2014-12-01 |
2016-06-09 |
Vtv Therapeutics Llc |
Inhibiteurs de bach1 en combinaison avec des activateurs de nrf2 et compositions pharmaceutiques les contenant
|
US10166218B2
(en)
|
2015-08-03 |
2019-01-01 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
WO2017023972A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines et leurs utilisations thérapeutiques
|
US10285983B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-B] pyridines and therapeutic uses thereof
|
WO2017023989A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[4,3-b]pyridines et leurs utilisations thérapeutiques
|
US10206909B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017023984A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines et leurs utilisations thérapeutiques
|
WO2017023986A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-indol-2-yl)-1h-indazoles et leurs utilisations thérapeutiques
|
WO2017024010A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-indazoles et leurs utilisations thérapeutiques
|
US10383861B2
(en)
|
2015-08-03 |
2019-08-20 |
Sammumed, LLC |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
US10519169B2
(en)
|
2015-08-03 |
2019-12-31 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017023993A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-indol-2-yl)-1h-pyrazolo[4,3-b]pyridines et leurs utilisations thérapeutiques
|
US10226448B2
(en)
|
2015-08-03 |
2019-03-12 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof
|
US10285982B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
WO2017023988A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines et leurs utilisations thérapeutiques
|
WO2017024021A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles et leurs utilisations thérapeutiques
|
US10231956B2
(en)
|
2015-08-03 |
2019-03-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10329309B2
(en)
|
2015-08-03 |
2019-06-25 |
Samumed, Llc |
3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
EP3370721A4
(fr)
|
2015-11-06 |
2019-05-22 |
Samumed, LLC |
Traitement de l'ostéoarthrite
|
WO2017087608A1
(fr)
|
2015-11-20 |
2017-05-26 |
Vitae Pharmaceuticals, Inc. |
Modulateurs de ror-gamma
|
TWI757266B
(zh)
*
|
2016-01-29 |
2022-03-11 |
美商維它藥物有限責任公司 |
ROR-γ調節劑
|
WO2017156071A1
(fr)
|
2016-03-09 |
2017-09-14 |
Blade Therapeutics, Inc. |
Composés céto-amides cycliques utilisés en tant que modulateurs de la calpaïne, et leurs procédés de production et d'utilisation
|
JP7010851B2
(ja)
|
2016-06-01 |
2022-02-10 |
バイオスプライス セラピューティクス インコーポレイテッド |
N-(5-(3-(7-(3-フルオロフェニル)-3H-イミダゾ[4,5-c]ピリジン-2-イル)-1H-インダゾール-5-イル)ピリジン-3-イル)-3-メチルブタンアミドを調製するための方法
|
EP3478269A4
(fr)
|
2016-06-29 |
2020-04-08 |
Otonomy, Inc. |
Formulations otiques à base de triglycérides et leurs utilisations
|
US11292801B2
(en)
|
2016-07-05 |
2022-04-05 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
EP3515904B1
(fr)
|
2016-09-20 |
2024-01-17 |
Centre Léon Bérard |
Benzimidazole en tant que medicament contre le cancer
|
CA3038331A1
(fr)
|
2016-09-28 |
2018-04-05 |
Blade Therapeutics, Inc. |
Modulateurs de calpain et leurs utilisations therapeutiques
|
BR112019008061A2
(pt)
|
2016-10-21 |
2019-09-17 |
Samumed Llc |
métodos de uso de indazol-3-carboxamidas e seu uso como inibidores da via de sinalização de wnt/b-catenina
|
US10758523B2
(en)
|
2016-11-07 |
2020-09-01 |
Samumed, Llc |
Single-dose, ready-to-use injectable formulations
|
WO2019018975A1
(fr)
|
2017-07-24 |
2019-01-31 |
Vitae Pharmaceuticals, Inc. |
Inhibiteurs de ror gamma
|
IL298639A
(en)
|
2017-07-24 |
2023-01-01 |
Vitae Pharmaceuticals Llc |
Inhibitors of gamma ror
|
US10584306B2
(en)
|
2017-08-11 |
2020-03-10 |
Board Of Regents Of The University Of Oklahoma |
Surfactant microemulsions
|
US11447482B1
(en)
|
2019-02-14 |
2022-09-20 |
KUDA Therapeutics, Inc. |
Imidazopyridine and oxazolopyridine derivatives and analogs thereof, methods of preparation thereof, methods of HIF-2A pathway inhibition, and induction of ferroptosis
|